Seegene is a leading developer of multiplex molecular assays and automated solutions for US labs
Check out our full menu of Research Use Only PCR assays
Novaplex™ MPXV Assay*
Single-tube assay to detect Monkeypox Virus
Novaplex MPXV (Monkeypox Virus) Assay (RUO)* is a real-time PCR product that is designed to detect MPXV target gene specifically with a single test. This product can be used with Seegene’s automation solution as well as other automation solutions for a convenient workflow.
*For Research Use Only. Not for use in Diagnostic Procedures
What You Need to Know About SARS-CoV-2 Variant Tracking - Omicron, BA.2 Omicron and others
Tracking, researching, and responding to variants is now an important part of our global health response to the COVID-19 pandemic. Understanding the implications of these different mutations (and their combined impact) is a key part of this strategy.
Seegene's response to the Omicron Variant
Introducing Seegene Mobile Station
High Multiplex RT-PCR Testing for COVID-19 and Other Pathogens
Seegene Allplex™ and Novaplex™ Assays
* Research Use Only
COVID-19: Find the solution that's right for you...
What’s New
Seegene develops PCR test to detect Monkeypox Virus
Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business
Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary
The Pitfalls of At-Home COVID-19 Testing
Is the pandemic ending? Is COVID-19 now endemic?
Blog & Press Releases
Seegene develops PCR test to detect Monkeypox Virus
Published on: PR Newswire SEOUL, South Korea, June 28, 2022 /PRNewswire/ — Seegene Inc. (KQ965390), South Korea’s leading molecular diagnostics (MDx) company has developed a PCR test to detect the monkeypox virus.
Celebrate DNA Day!
Congress approved the first National DNA Day in April 2003 to celebrate both the completion of the Human Genome Project and the 50th anniversary of
The Pitfalls of At-Home COVID-19 Testing
Throughout the COVID-19 pandemic, identifying individuals who have been infected with SARS-CoV-2 in a reliable and timely manner has been a crucial strategy in controlling
Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary
Published on: PR Newswire SEOUL, South Korea, March 17, 2022 /PRNewswire/ — Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today announced the appointment of Glen Hansen, Ph.D., D(ABMM), FCCM, as